Clinical Study of PGT-A Versus PGT-A+ERA

NATerminatedINTERVENTIONAL
Enrollment

368

Participants

Timeline

Start Date

May 28, 2018

Primary Completion Date

February 22, 2022

Study Completion Date

February 22, 2022

Conditions
Infertility of Uterine Origin
Interventions
DIAGNOSTIC_TEST

PGT-A

PGT-A will be carried out following the usual clinical practice. Trophectoderm biopsy samples from blastocysts are analyzed by NGS to screen for numerical chromosomal abnormalities.

DIAGNOSTIC_TEST

ERA Test

The ERA test requires an endometrial biopsy and will determine if the endometrium is receptive or not by analysing the expression levels of 236 genes involved in endometrial receptivity, to assess the optimal time to place an embryo into the uterus and promote a successful implantation and pregnancy.

Trial Locations (15)

302

Taiwan IVF Group, Zhubei

6800

Shady Grove Fertility Chile, Vitacura

28108

Milenium Centro Médico y de Bienestar de Alcobendas - Sanitas, Alcobendas

92663

Ovation Fertility Newport Beach, Newport Beach

110024

Mother And Child Hospital, Defence Colony

500034

OASIS centre for reproductive medicine, Banjara Hills

01867

Fertility Centers of New England, Reading

C1425

Pregna Medicina Reproductiva, CABA

01332000

Vida Bem Vinda, São Paulo

BC V5Z 3X7

Olive Fertility Center, Vancouver

0179

Georgian- American Center for Reproductive Medicine ReproART, Tbilisi

05120

NASCERE, Mexico City

06006

Instituto Extremeño de Reproducción Asistida S.L. (IERA), Badajoz

07720

Bahceci Group, Istanbul

Unknown

Vinmec Time City International Hospital, Hà Nội

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Igenomix

INDUSTRY

NCT03530254 - Clinical Study of PGT-A Versus PGT-A+ERA | Biotech Hunter | Biotech Hunter